A Case of Nonpuerperal Uterine Inversion Caused by Cervical Cancer.


Journal

Case reports in obstetrics and gynecology
ISSN: 2090-6684
Titre abrégé: Case Rep Obstet Gynecol
Pays: United States
ID NLM: 101576454

Informations de publication

Date de publication:
2022
Historique:
received: 09 10 2021
accepted: 12 01 2022
entrez: 10 2 2022
pubmed: 11 2 2022
medline: 11 2 2022
Statut: epublish

Résumé

Uterine inversion is a rare puerperal event in the third stage of labor. Nonpuerperal uterine inversion is even rarer and is mainly caused by uterine fibroids, uterine sarcoma, or endometrial cancer. This is the first report of uterine inversion caused by cervical cancer. A 67-year-old woman presented with a 10 cm pelvic mass. Contrast-enhanced magnetic resonance imaging revealed uterine inversion, which was preoperatively diagnosed to be caused by endometrial cancer and was treated using an extended abdominal hysterectomy. Postoperative histopathological examination revealed that the primary tumor was a squamous cell carcinoma with coexistent high-grade squamous intraepithelial lesions and small-cell neuroendocrine carcinoma. Immunostaining was diffusely positive for p16 and negative for estrogen receptors. The postoperative diagnosis was cervical squamous cell carcinoma. Our observations suggested that cervical carcinoma can cause uterine inversion by invading the corpus.

Identifiants

pubmed: 35140992
doi: 10.1155/2022/1630192
pmc: PMC8820920
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1630192

Informations de copyright

Copyright © 2022 Daiki Hiratsuka et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

J Obstet Gynaecol Res. 2019 Feb;45(2):466-472
pubmed: 30187623
BMC Cancer. 2018 May 4;18(1):530
pubmed: 29728073
Int J Surg Case Rep. 2013;4(11):1000-3
pubmed: 24091076
BMJ Case Rep. 2018 Jan 29;2018:
pubmed: 29378741
BMJ Case Rep. 2013 Dec 12;2013:
pubmed: 24334469
J Comput Assist Tomogr. 1989 Mar-Apr;13(2):357-9
pubmed: 2647797
Jpn J Clin Oncol. 2001 Jan;31(1):39-42
pubmed: 11256840
Obstet Gynecol Int. 2020 Jun 1;2020:8625186
pubmed: 32565821
J Med Case Rep. 2010 Jan 24;4:21
pubmed: 20205761
Aging Clin Exp Res. 2014 Oct;26(5):543-5
pubmed: 24615329
Eur J Surg Oncol. 2017 Apr;43(4):725-734
pubmed: 28215507
Case Rep Womens Health. 2019 Mar 08;22:e00107
pubmed: 30923682

Auteurs

Daiki Hiratsuka (D)

Department of Obstetrics and Gynecology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Takehiro Tsukazaki (T)

Department of Obstetrics and Gynecology, Showa General Hospital, 8-1-1 Hanakoganei, Kodaira-shi, Tokyo, Japan.

Kenbun Sone (K)

Department of Obstetrics and Gynecology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Kazuaki Neriishi (K)

Department of Obstetrics and Gynecology, Showa General Hospital, 8-1-1 Hanakoganei, Kodaira-shi, Tokyo, Japan.

Kimihiro Takechi (K)

Department of Obstetrics and Gynecology, Showa General Hospital, 8-1-1 Hanakoganei, Kodaira-shi, Tokyo, Japan.

Classifications MeSH